Animal studies comparing the neuropharmacological profile of a trifluoperazine HCl-amobarbital combination with that of the individual components.
D000654:Amobarbital / Q000494:pharmacology; D000818:Animals; D002490:Central Nervous System / Q000187:drug effects*; D002707:Chlordiazepoxide / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D006990:Hypnosis; D008297:Male; D008620:Meprobamate / Q000494:pharmacology; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D051381:Rats; D012640:Seizures / Q000188:drug therapy; D012890:Sleep; D013997:Time Factors; D014268:Trifluoperazine / Q000494:pharmacology*
D014268:Trifluoperazine; D002707:Chlordiazepoxide; D008620:Meprobamate; D000654:Amobarbital; D010433:Pentylenetetrazole